A clause scanner can organise supplied wording; it cannot establish enforceability or determine the law.
Affected arrangements: Buyers reviewing minimum volumes, deposits, exclusivity and transition obligations.
Anchor each issue to the text
Use a redacted contract and preserve page or section markers. Capture the exact wording governing products, states, parties, price changes, minimum purchases, allocation, termination and records access. If no clause is supplied, label it not found in supplied text, not absent from the contract. A keyword match is a prompt for review rather than a legal conclusion.
Calculate only declared commitments
If the document expressly states a monthly minimum, unit price and remaining committed months, a simple gross commitment can multiply those inputs. Separately identify deposits, credits, purchase amounts already satisfied and possible mitigation. Do not add a deposit twice when it is credited against purchases. Do not label the result damages or enforceable liability.
Test route-change scenarios
Ask how the agreement handles product unavailability, a changed regulatory basis, licence changes, recalls and delayed fulfilment. Identify notice requirements, refund provisions, allocation discretion and the documents needed to move work. Compare these terms with the actual access workflow rather than assuming the clinic controls every step.
Prepare counsel's agenda
Export the clause, issue, commercial implication, unanswered question and negotiation owner. Explain the proposed operational fallback and any dependency on another pharmacy or platform. Qualified counsel determines the legal effect and suitable drafting. The procurement team's useful output is a coherent review pack that makes commitments and transition needs visible before signature.
Questions to take forward
- Can the proposed product or state scope change unilaterally?
- Are deposits credited, refundable or separate?
- What data and support are available when the relationship ends?
Primary sources & evidence limits
FDA: GLP-1 compounding policies and dated shortage milestones ↗Latest dated update retrieved: 1 April 2026 · Accessed 2026-11-17LillyDirect: Patient FAQs and workflow ↗Publication date not stated · Accessed 2026-11-17NovoCare: Home delivery information for healthcare professionals ↗Publication date not stated · Accessed 2026-11-17Primary-source links were opened or retrieved on 17 November 2026. This date records source access, not legal or clinical review. Procurement checklists and commercial models are editorial methods. No live supplier, licence, coverage or capacity verification has been performed.